These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8621385)

  • 1. Temperature and pH dependence of fluorescein binding within the monoclonal antibody 9-40 active site as monitored by hydrostatic pressure.
    Carrero J; Voss EW
    J Biol Chem; 1996 Mar; 271(10):5332-7. PubMed ID: 8621385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure-induced dissociation of fluorescein from the anti-fluorescein single-chain antibody 4-4-20.
    Coelho-Sampaio T; Voss EW
    Biochemistry; 1993 Oct; 32(41):10929-35. PubMed ID: 8218158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-metatype antibodies stabilize the fluorescein single-chain antibody 4-4-20 complex against dissociation by hydrostatic pressure.
    Coelho-Sampaio T; Voss EW
    J Biol Chem; 1994 Mar; 269(11):8146-52. PubMed ID: 8132540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
    Mallender WD; Carrero J; Voss EW
    J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative binding properties of fluorescein and 9-hydroxyphenylfluoron (HPF) with murine monoclonal anti-fluorescein antibodies.
    Bedzyk WD; Swindlehurst CA; Voss EW
    Biochim Biophys Acta; 1992 Feb; 1119(1):27-34. PubMed ID: 1540631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand binding to anti-fluorescyl antibodies: stability of the antigen binding site.
    Müller JD; Nienhaus GU; Tetin SY; Voss EW
    Biochemistry; 1994 May; 33(20):6221-7. PubMed ID: 8193136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of secondary forces on the ligand binding and conformational state of antifluorescein monoclonal antibody 9-40.
    Mummert ME; Voss EW
    Biochemistry; 1997 Sep; 36(39):11918-22. PubMed ID: 9305985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence measurements of immune complexes of Mab 4-4-20 with isomeric haptens.
    Swindlehurst CA; Voss EW
    Biophys J; 1991 Mar; 59(3):619-28. PubMed ID: 1904783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, characterization, and mutagenesis of an anti-fluorescein single chain antibody idiotype family.
    Denzin LK; Voss EW
    J Biol Chem; 1992 May; 267(13):8925-31. PubMed ID: 1577730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
    Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site contributions to fluorescein binding determined by in vitro heavy and light chain reassociations.
    Bedzyk WD; Voss EW
    Mol Immunol; 1991; 28(1-2):27-34. PubMed ID: 2011128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of secondary forces on the ligand binding properties and variable domain conformations of a monoclonal anti-fluorescyl antibody.
    Mummert ME; Voss EW
    Mol Immunol; 1996 Sep; 33(13):1067-77. PubMed ID: 9010246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives.
    Tetin SYu ; Mantulin WW; Denzin LK; Weidner KM; Voss EW
    Biochemistry; 1992 Dec; 31(48):12029-34. PubMed ID: 1457402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.
    Ahlers M; Grainger DW; Herron JN; Lim K; Ringsdorf H; Salesse C
    Biophys J; 1992 Sep; 63(3):823-38. PubMed ID: 1420916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity rat anti-fluorescein monoclonal antibody with unique fine specificity properties including differential recognition of dynamic ligand analogues.
    Miklasz SD; Gulliver GA; Voss EW
    J Mol Recognit; 1995; 8(4):258-69. PubMed ID: 8588943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ligand binding by monoclonal anti-fluorescyl antibodies.
    Kranz DM; Herron JN; Voss EW
    J Biol Chem; 1982 Jun; 257(12):6987-95. PubMed ID: 6806261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of active site contact residues in anti-fluorescein monoclonal antibody 4-4-20.
    Denzin LK; Gulliver GA; Voss EW
    Mol Immunol; 1993 Oct; 30(15):1331-45. PubMed ID: 8232321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metatype antibody stabilization of Fv 4-4-20 variable domain dynamics.
    Carrero J; Mallender WD; Voss EW
    J Biol Chem; 1996 May; 271(19):11247-52. PubMed ID: 8626674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic properties of ligand binding by monoclonal anti-fluorescyl antibodies.
    Herron JN; Kranz DM; Jameson DM; Voss EW
    Biochemistry; 1986 Aug; 25(16):4602-9. PubMed ID: 3768301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical and spectroscopic characterization of two fluorescein 5'-isothiocyanate labeling sites on Na+,K(+)-ATPase.
    Abbott AJ; Amler E; Ball WJ
    Biochemistry; 1991 Feb; 30(6):1692-701. PubMed ID: 1847073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.